News and Opinions
Novel, Less Toxic, Stem Cell Transplant Prep Yields Successful Outcomes
By Genectic Engineering & Biotechnology - Phase I clinical trial results suggest that an antibody treatment, used in combination with other drugs, enabled stem cell transplants for three children with Fanconi anemia without toxic busulfan chemotherapy or radiation....
Florida Is Now a Haven for Unproven Stem-Cell Treatments
By Emily Mullin - WIRED - Florida is the latest state to sidestep the authority of the Food and Drug Administration by allowing patients to access certain stem-cell treatments that have not been rigorously evaluated and approved. Under a new law that went into effect...
Engineering immune cells within the body
By National institutes of Health - Chimeric antigen receptor (CAR) T cell therapies involve taking immune cells, called T cells, from a patient and engineering them to make a protein that lets them recognize and attack the patient’s cancer cells. CAR T cells have...
We need new regulation to keep up with longevity innovation
By Danny Sullivan - Longevity.Technology - Healthspan Action Coalition's Bernard Siegel says new state laws show the federal government needs to ‘get its act together’ on patient access to innovative therapies. As a member of the Florida Bar Association for the past...
Mesenchymal stem cell therapy shows potential: Study review
by Steve Bryson, PhD - Multiple Sclerosis Today - More study needed to support evidence, researchers say. Mesenchymal stem cell (MSC) therapy is safe and well tolerated, and leads to improvements in disability and a reduction in lesion burden in people with multiple...
Ankles may hold the key to new osteoarthritis therapy
by Duke University - Futurity - The ankle’s ability to regenerate cartilage uses the same mechanisms that enable some animals to grow new limbs, and it could be harnessed to repair cartilage in knees and hips hobbled by osteoarthritis. Those findings in the journal...
3D Bioprinting: How The Future of Medicine is Being Built, Layer by Layer
By Kevin Famuyiro - The Los Angeles Times - For years it’s been science fiction: printing a spare part for the human body on demand. But today in labs around the world that fiction is becoming a reality. 3D bioprinting, the marriage of biology and engineering, allows...
Stem Cell Bank Targets Alzheimer’s Genetic Risk
By Technology Networks Genomics Research - New stem cell platform models Alzheimer's risk using cells from people with high and low genetic predisposition. Researchers at the UK Dementia Research Institute at Cardiff University have developed a new stem cell resource...
Fixing Sugar Metabolism Shows Promise Against Dementia
by Arkadi Mazin - Lifespan Research Institute - This may have effects on a significant component of Alzheimer's. Scientists have shown that aberrant metabolism of glycogen in neurons is linked to the accumulation of harmful tau protein. Caloric restriction, genetic...
This is Not the Time to Cut Space-enabled Medical Research
By Nicole Wagner - ISS National Laboratory = Research that leverages space to develop treatments for blindness, cancer, and Parkison’s disease is jeopardized by the $6.1 billion NASA budget cuts recently announced for 2026 by President Trump. The cuts to the...
Adult stem cells discovered in small, non-human primate for first time
by Aarhus University - MedicalXpress - For the first time, researchers have discovered and isolated adult stem cells from a non-human primate. This finding could transform the foundation for how we develop stem cell treatments. Stem cell therapy is a relatively new...
Squeezing Through Narrow Spaces Prompts Stem Cells To Turn Into Bone Cells
By Technology Networks - In a discovery that could reshape approaches to regenerative medicine and bone repair, researchers have found that human stem cells can be prompted to begin turning into bone cells simply by squeezing through narrow spaces. The study suggests...
Neural Stem Cell Grafts Restore Myelin in MS-Like Lesions in Mice
By - inside Precision Medicine - A new study led by scientists at the University of Cambridge has shown that induced neural stem cell (iNSC) grafts can successfully generate myelin-producing cells in mice with lesions similar to those seen in progressive multiple...
Pentagon seeks sensors to aid regenerative medicine
By Lauren C. Williams - Defense One - And as a byproduct, to boost the U.S. biotech industry. The Pentagon is looking for tiny sensors that track the health of biological tissue, part of an effort to help soldiers recover from wounds—and give the U.S. biotech industry...
How the First Customized Gene Therapy Was Created in Six Months
by Molly Coddington - Technology Networks - CRISPR gene therapy is changing the future of rare genetic disorder treatments. In May, news broke that a 10-month-old baby, KJ Muldoon, was doing well after receiving 3 doses of the world’s first personalized CRISPR...
Mice Regenerate Ear Tissue When Vitamin A Genetic Switch is Flipped
By Genetic Engineering and Biotechnology News - By flipping an evolutionarily disabled genetic switch involved in vitamin A metabolism, researchers headed by a team at the National Institute of Biological Sciences, Beijing, have enabled ear tissue regeneration in...
Releasing a molecular ‘brake’ may help immune cells better fight cancer
By Van Andel Institute - Grand Rapids, MI - Van Andel Institute scientists and collaborators have discovered a potential treatment target that may re-energize dysfunctional or “exhausted” immune cells in their fight against cancer. The target is an immune checkpoint...
Partial Match Parity: Increasing the Donor Pool for Hematopoietic Stem Cell Transplantation
By: Charlotte Schubert, Ph.D. - University of Miami Miller School of Medicine - Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options. A new study shows that patients achieve good outcomes with an partial...
“Leukemia-on-a-Chip” Offers a New Tool for Screening CAR T-Cell Therapy
By Technology Networks - Chimeric antigen receptor (CAR) T cell therapy represents a breakthrough in cancer treatment. By harnessing the body’s immune system, CAR T therapy provides a powerful, personalized treatment option that can be particularly effective for...
3 progressive MS patients see lower disability with CAR T-cell therapy
by Marisa Wexler - Multiple Sclerosis News Today - A CAR T-cell therapy from Iaso Biotherapeutics was tolerated well and led to marked improvements in disability for three people with progressive forms of multiple sclerosis (MS), according to early data from a Phase 1...
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.



















